Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options
Tech-Powered Skincare Franchise Opens Six New Studios, Signs 11 New Leases, and Attracts Repeat Investment Across Key Markets
WASHINGTON, Aug. 12, 2025 /PRNewswire/ -- GLO30,...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.
Fredhopper Launches App to Bring AI-Powered Product Discovery to Shopify Enterprise Merchants
LONDON, Aug. 11, 2025 /PRNewswire/ -- Crownpeak today announced the launch of the...
Viewers will have the opportunity to bundle ESPN's DTC Unlimited Offering and FOX One for $39.99 per month Starting October 2
BRISTOL, Conn. and LOS...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 30, 2025.
NEW ORLEANS, Aug. 8, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file...
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit.
MADISON, Wis., Aug. 8, 2025 /PRNewswire/ -- Madison Liquidators, a leading supplier of premium office furniture, is proud to announce the release of The Ultimate...
SANTA CLARA, Calif., Aug. 8, 2025 /PRNewswire/ -- Digital transformation software and solutions company -Trianz is pleased to announce that its Cloud Management platform,...
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower revenue recognized per customer specific to its so-called personalized GLP-1 component, a medication the company compounds to treat weight loss.
New Sinch survey reveals trust, not just technology, will influence which brands break through this holiday season
STOCKHOLM, Aug. 6, 2025 /PRNewswire/ -- Sinch AB...
NEW YORK and NEW ORLEANS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’s securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Northern District of California.